Digital Evidence Base

Trusted Knowledge for Informed Decisions

Filters
SDGs
Priority Areas
Research Outcomes
Document Type
Year
4019 results found
Show:
Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda
Levin J., Hughes P., Kaleebu P., Todd J., Kityo C., Ssali F., Goodall R.L., Dunn D.T., Pattery T., Van Cauwenberge A., Nkurunziza P., Awio P., Ndembi N., Munderi P., Gilks C.F., Pillay D., Chirara M., Dunn D., Gibb D.M., Gilks C., Goodall R., Kapaata A., Katuramur M., Lyagoba F., Magala R., Magambo B., Mataruka K., Mccormick A., Mugarura L., Musunga T., Nabankkema M., Nkalubo J., Parry C., Robertson V., Spyer M., Yirrell D., Grosskurth H., Kabuye G., Nsibambi D., Kasirye R., Zalwango E., Nakazibwe M., Kikaire B., Nassuna G., Massa R., Fadhiru K., Namyalo M., Zalwango A., Generous L., Khauka P., Rutikarayo N., Nakahima W., Mugisha A., Muyingo S., Ruberantwari A., Aber M., Medina lara A., Foster S., Amurwon J., Nyanzi Wakholi B., Mugyenyi P., Tumukunde D., Otim T., Kabanda J., Musana H., Akao J., Kyomugisha H., Byamukama A., Sabiiti J., Komugyena J., Wavamunno P., Mukiibi S., Drasiku A., Byaruhanga R., Labeja O., Katundu P., Tugume S., Namazzi A., Bakeinyaga G.T., Katabira H., Abaine D., Tukamushaba J., Anywar W., Ojiambo W., Angweng E., Murungi S., Haguma W., Atwiine S., Kigozi J., Latif A., Hakim J., Reid A., Chidziva E., Bulaya-tembo R., Musoro G., Taziwa F., Chimbetete C., Chakonza L., Mawora A., Muvirimi C., Tinago G., Svovanapasis P., Simango M., Chirema O., Machingura J., Mutsai S., Phiri M., Bafana T., Muchabaiwa L., Muzambi M., Katabira E., Ronald A., Kambungu A., Lutwama F., Nanfuka A., Walusimbi J., Nabankema E., Nalumenya R., Namuli T., Kulume R., Namata I., Nyachwo L., Florence A., Kusiima A., Lubwama E., Nairuba R., Oketta F., Buluma E., Waita R., Ojiambo H., Sadik F., Wanyama J., Nabongo P.
2014
DOI: 10.1093/jac/dku052
Abstract
Informed consent in blood transfusion: Knowledge and administrative issues in Uganda hospitals
Kajja I., Bimenya G.S., Smit Sibinga C.T.
2011
DOI: 10.1016/j.transci.2010.12.006
Abstract
"Current dementia care: what are the difficulties and how can we advance care globally?"
Giebel C
2020
DOI: 10.1186/s12913-020-05307-1

Background Dementia is a growing global public health concern, with post-diagnostic care often very limited. Depending on where people live, both within a country and depending on high-, middle-, and …

Abstract
The orphaning experience: Descriptions from Ugandan youth who have lost parents to HIV/AIDS
Harms S, Jack S, Ssebunnya J, Kizza R
2010
DOI: 10.1186/1753-2000-4-6

The HIV/AIDS epidemic has continued to pose significant challenges to countries in Sub-Saharan Africa. Millions ofAfrican children and youth have lost parents to HIV/AIDS leaving a generation of orphans to …

Abstract
Better nutrition for children in Uganda The policy makers role
Kasirye Ibrahim
2012

Uganda has made tremendous progress in improving welfare outcomes in the past 20 years, some key welfare outcomes especially regarding nutritional status have performed dismally. For instance, the proportion of …

Abstract
Depression, alcohol use, and intimate partner violence among outpatients in rural Uganda: vulnerabilities for HIV, STIs and high risk sexual behavior
Wanyenze RK, Lule H, Kiene SM, Sileo KM, Silmi KP
2017
DOI: 10.1186/s12879-016-2162-2

Background: Intimate partner violence (IPV), alcohol use, and depression are key vulnerabilities for HIV in Uganda, and taken together may have a synergistic effect on risk. Our objective was to …

Abstract
Erratum to: Expanded Quality Management Using Information Power (EQUIP): protocol for a quasi-experimental study to improve maternal and newborn health in Tanzania and Uganda
Waiswa Peter, Hanson Claudia, Marchant Tanya, Marx Michael, Manzi Fatuma, Mbaruku Godfrey, Rowe Alex, Tomson Göran, Schellenberg Joanna, Peterson Stefan, Team Equip Study
2015
Abstract
Effect of high-intensity versus low-intensity praziquantel treatment on HIV disease progression in HIV and Schistosoma mansoni co-infected patients: a randomised controlled trial
Abaasa A., Kamali A., Asiki G., Obuku Ekii A., Wanyenze J., Pala P., G J. van Dam, Corstjens Plam, Hughes P., Ding S., Pantaleo G., Kaleebu P., Elliott A. M.
2018
DOI: 10.12688/wellcomeopenres.14683.2

Background: It has been hypothesised that Schistosoma co-infection exacerbates HIV progression, and hence anthelminthic intervention in co-infected individuals will delay it. We evaluated effects of high-intensity versus low-intensity praziquantel treatment …

Abstract
Apabetalone downregulates fibrotic, inflammatory and calcific processes in renal mesangial cells which may contribute to reduced cardiac events observed in ckd patients
Gilham D., Fu L., Rakai B., Wasiak S., Tsujikawa L., Halliday C., Sarsons C., Stotz S., Jahagirdar R., Johansson J., Sweeney M., Wong N., Kalantar-Zadeh K., Kulikowski E.
2021
DOI: 10.1093/ndt/gfab078.008

BACKGROUND AND AIMS: Major adverse cardiac events (MACE) remain a leading cause of mortality in chronic kidney disease (CKD). Apabetalone is an orally available inhibitor of bromodomain & extraterminal (BET) …

Abstract
AI Research Assistant
AI-powered research assistance. Uses the Digital Evidence Base as the Knowledge source.